- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
6127
HKG
Week ended 07 Aug 2026
Weekly Investor Report
Joinn Laboratories(China)Co.,Ltd. · Healthcare · Diagnostics & Research
Latest close
27.50 HKD
24.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 30.7% above the Trend Line and sits at 83.3% of its 52-week range. The latest completed week returned 24.0%, after a 35.3% four-week move. The latest news-sentiment score is 50/100.
Setup score
59
out of 100
Latest Close
27.50 HKD
7 Aug 2026
1W Return
24.0%
latest completed week
4W Return
35.3%
short-term follow-through
12W Return
35.1%
quarterly tape
Trend Breadth
36.5%
19 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 42.54% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 1 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
24.0%
Latest completed week; four-week move 35.3%.
Indicator stack
20/96
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.54%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 30.7% above the Trend Line and sits at 83.3% of its 52-week range. The latest completed week returned 24.0%, after a 35.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2412-week average 0.28
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.24Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 35.3% over four weeks, 35.1% over 12 weeks, and 27.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year19
Trend breadth36.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.09Latest activity-pressure read.
Pressure change326.5%Four-week change in activity pressure.
Leadership31.20Latest relative-leadership reading.
RS change801.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.3%Distance below the 52-week high.
13-week volatility9.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+24.0%Week of 7 Aug.
Worst week-15.2%Week of 20 Mar.
Latest week+24.0%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains3
Flat weeks0
Modest losses7
Sharp losses7
Recent vol9.3%13-week weekly-return volatility.
Base vol10.0%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew9.5% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank3 / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Diagnostics & Research
4-week rank3 / 13
Group average12.4%
Trend breadth7.7%
Trend7.7%active weekly trend signals
MD61.5%positive activity pressure
RS46.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape52/100
Trend, activity pressure, participation, and risk combine to a 52/100 tape read.
Indicator analysis27/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 6/12.
Activity pressure 0.24; 1 reversal markers Next-Week ExpectancyNegative 42.54%Next-week expectancy is negative with a 42.54% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Enterprise value to EBITDA forward of JOINN Laboratories (China) Co., Ltd. Class H – HKEX:6127 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 27.50 HKD | 24.0% | 21.04 HKD | 14.50 HKD | 1.09 | 31.20 | 38.7M | Off |
| 31 Jul 2026 | 22.18 HKD | -9.3% | 21.00 HKD | 14.43 HKD | 0.82 | 5.43 | 35.6M | Off |
| 24 Jul 2026 | 24.46 HKD | 2.9% | 20.92 HKD | 14.41 HKD | 0.50 | 20.31 | 58.6M | Off |
| 17 Jul 2026 | 23.76 HKD | 16.9% | 20.83 HKD | 14.38 HKD | 0.03 | 18.82 | 164.0M | Off |
| 10 Jul 2026 | 20.32 HKD | 4.3% | 20.77 HKD | 14.35 HKD | -0.48 | 3.46 | 28.5M | Off |
| 3 Jul 2026 | 19.49 HKD | 7.6% | 20.80 HKD | 14.35 HKD | -0.85 | 2.69 | 3.8M | Off |
| 26 Jun 2026 | 18.12 HKD | 4.7% | 20.69 HKD | 14.35 HKD | -1.06 | -1.49 | 6.6M | Off |
| 19 Jun 2026 | 17.30 HKD | 6.2% | 20.64 HKD | 14.36 HKD | -1.18 | -10.51 | 11.2M | Off |
| 12 Jun 2026 | 16.29 HKD | -3.4% | 20.61 HKD | 14.36 HKD | -1.06 | -18.23 | 2.3M | Off |
| 5 Jun 2026 | 16.87 HKD | -5.5% | 20.72 HKD | 14.39 HKD | -0.79 | -16.20 | 3.7M | Off |
| 29 May 2026 | 17.85 HKD | -9.4% | 20.79 HKD | 14.42 HKD | -0.59 | -11.92 | 13.5M | Off |
| 22 May 2026 | 19.70 HKD | -3.2% | 20.91 HKD | 14.43 HKD | -0.37 | -4.14 | 22.5M | Off |
| 15 May 2026 | 20.36 HKD | 0.1% | 20.86 HKD | 14.43 HKD | -0.41 | -1.64 | 22.6M | On |
| 8 May 2026 | 20.34 HKD | -4.7% | 20.80 HKD | 14.43 HKD | -0.46 | -2.47 | 15.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.